NRl 572/l NR572l Finall Exam:l Advancedl
Acutel Carel Managementl Guidel (Latestl
2026/l 2027l Update)l |l Qsl &l As|l Gradel A|l
100%l Correctl (Verifiedl Answers)-l
Chamberlain
QUESTION
Screeningl toolsl forl depression
Answer:
QIDSl Clinician,l QIDSl SelfReport,l PHQ9
QUESTION
PHQ-9
Answer:
9iteml selfreportl forl depressionl severity;l usefull forl identifyingl severel depression
QUESTION
QIDSl Clinicianl Report
Answer:
16iteml depressionl scale:l 0-5:l none,l 6-10:l mild,l 11-15:l moderate,l 16-20:l severe,l 21+:l
veryl severe
QUESTION
Non-psychiatricl managementl ofl psychosis
Answer:
,OKl ifl chronic/stablel andl psychl consultl unavailable;l continuel previousl treatment
QUESTION
Benzodiazepinel sidel effects
Answer:
Sedation;l paradoxicall agitation;l dependence;l withdrawal
QUESTION
Benzodiazepinel precautions
Answer:
Avoidl withl CNSl depressants;l cautionl inl liverl disease,l elderly,l mentallyl ill,l respiratoryl
disease
QUESTION
Assessingl substance-abusel andl depression
Answer:
Antidepressantsl canl bel dangerousl withl alcohol;l assessl forl sedativel abuse;l usel labsl andl
collateral
QUESTION
Treatmentl forl substance-abusel withl depression
Answer:
Stopl intoxicant;l treatl onlyl afterl sobriety;l considerl 4l weeksl beforel startingl meds
QUESTION
Postpartuml depressionl (PPD)
Answer:
MDDl withl postpartuml onsetl withinl 1l monthl ofl childbirth;l usel Edinburghl scale
,QUESTION
Riskl factorsl forl PPD
Answer:
Depressionl history;l PMS;l stress;l poorl support;l lowl income;l youngl age;l immigration
QUESTION
Medicationsl forl PPD
Answer:
Sertraline,l paroxetine,l nortriptyline,l imipramine
QUESTION
Unsafel PPDl meds
Answer:
Doxepinl (sedation,l respiratoryl depression,l contraindicatedl inl breastfeeding)
QUESTION
Centrall vsl Obstructivel Sleepl Apnea
Answer:
Centrall =l nol effortl tol breathe,l nol snoring;l brainl doesn'tl sendl signal
QUESTION
Pheochromocytomal triad
Answer:
Palpitations;l sweating;l headaches
, QUESTION
Pheochromocytomal complications
Answer:
Hypertensivel crisis;l MI
QUESTION
Pheochromocytomal definition
Answer:
Benignl adrenall medullal tumorl producingl excessl catecholamines
QUESTION
PTSDl criterial (E-H)
Answer:
E.l Symptomsl ofl increasedl arousal,l includingl atl leastl twol ofl thel following:l sleepl
difficulties,l irritability,l poorl concentration,l hypervigilance,l recklessl behavior,l orl
exaggeratedl startlel response.l F.l Durationl isl morel thanl onel month.l G.l Thel disturbancel
causesl distressl orl impairment.l H.l Thel disturbancel isl notl attributablel tol thel effectsl ofl
substancel orl anotherl medicall condition.
QUESTION
Clinicall presentationl ofl MDD
Answer:
Sadness,l indifference,l apathy,l orl irritability,l usuallyl associatedl withl changesl inl sleepl
patterns,l appetite,l andl weight.l Fatigue.l Impairedl concentrationl andl decision-making.l Theyl
oftenl feell finel andl euphoricl inl thel morning.
QUESTION
Medicationsl notl tol usel forl PTSD
Answer:
Acutel Carel Managementl Guidel (Latestl
2026/l 2027l Update)l |l Qsl &l As|l Gradel A|l
100%l Correctl (Verifiedl Answers)-l
Chamberlain
QUESTION
Screeningl toolsl forl depression
Answer:
QIDSl Clinician,l QIDSl SelfReport,l PHQ9
QUESTION
PHQ-9
Answer:
9iteml selfreportl forl depressionl severity;l usefull forl identifyingl severel depression
QUESTION
QIDSl Clinicianl Report
Answer:
16iteml depressionl scale:l 0-5:l none,l 6-10:l mild,l 11-15:l moderate,l 16-20:l severe,l 21+:l
veryl severe
QUESTION
Non-psychiatricl managementl ofl psychosis
Answer:
,OKl ifl chronic/stablel andl psychl consultl unavailable;l continuel previousl treatment
QUESTION
Benzodiazepinel sidel effects
Answer:
Sedation;l paradoxicall agitation;l dependence;l withdrawal
QUESTION
Benzodiazepinel precautions
Answer:
Avoidl withl CNSl depressants;l cautionl inl liverl disease,l elderly,l mentallyl ill,l respiratoryl
disease
QUESTION
Assessingl substance-abusel andl depression
Answer:
Antidepressantsl canl bel dangerousl withl alcohol;l assessl forl sedativel abuse;l usel labsl andl
collateral
QUESTION
Treatmentl forl substance-abusel withl depression
Answer:
Stopl intoxicant;l treatl onlyl afterl sobriety;l considerl 4l weeksl beforel startingl meds
QUESTION
Postpartuml depressionl (PPD)
Answer:
MDDl withl postpartuml onsetl withinl 1l monthl ofl childbirth;l usel Edinburghl scale
,QUESTION
Riskl factorsl forl PPD
Answer:
Depressionl history;l PMS;l stress;l poorl support;l lowl income;l youngl age;l immigration
QUESTION
Medicationsl forl PPD
Answer:
Sertraline,l paroxetine,l nortriptyline,l imipramine
QUESTION
Unsafel PPDl meds
Answer:
Doxepinl (sedation,l respiratoryl depression,l contraindicatedl inl breastfeeding)
QUESTION
Centrall vsl Obstructivel Sleepl Apnea
Answer:
Centrall =l nol effortl tol breathe,l nol snoring;l brainl doesn'tl sendl signal
QUESTION
Pheochromocytomal triad
Answer:
Palpitations;l sweating;l headaches
, QUESTION
Pheochromocytomal complications
Answer:
Hypertensivel crisis;l MI
QUESTION
Pheochromocytomal definition
Answer:
Benignl adrenall medullal tumorl producingl excessl catecholamines
QUESTION
PTSDl criterial (E-H)
Answer:
E.l Symptomsl ofl increasedl arousal,l includingl atl leastl twol ofl thel following:l sleepl
difficulties,l irritability,l poorl concentration,l hypervigilance,l recklessl behavior,l orl
exaggeratedl startlel response.l F.l Durationl isl morel thanl onel month.l G.l Thel disturbancel
causesl distressl orl impairment.l H.l Thel disturbancel isl notl attributablel tol thel effectsl ofl
substancel orl anotherl medicall condition.
QUESTION
Clinicall presentationl ofl MDD
Answer:
Sadness,l indifference,l apathy,l orl irritability,l usuallyl associatedl withl changesl inl sleepl
patterns,l appetite,l andl weight.l Fatigue.l Impairedl concentrationl andl decision-making.l Theyl
oftenl feell finel andl euphoricl inl thel morning.
QUESTION
Medicationsl notl tol usel forl PTSD
Answer:
